IDT Biologika nelle notizie
Produzione e sviluppo biofarmaceutico
Tamtam ha trovato 20 articoli recenti su IDT Biologika.
- SK bioscience cuts Q2 operating loss by 58% as IDT performance improves
- SK Bioscience Q2 Loss Narrows 58% as German Unit IDT Turnaround Gains Traction
- SK bioscience cuts Q2 operating loss by 58% as IDT performance improves
- SK Bioscience Halves Q2 Operating Loss on German Unit Recovery
- SK Bioscience Accelerates Growth on Vaccine and CDMO Momentum
- IDT Eyes Capacity Expansion, M&A to Build on SK Synergies
- IDT Biologika Enters CMDO Partnership to Accelerate Global Growth
- SK bioscience's Q1 revenue up 9% on IDT growth, vaccine distribution
- SK Bioscience stärkt globale Position durch Übernahme von IDT Biologika
- SK Bioscience Co Ltd Aktie (KR7302440009): Übernahme von IDT Biologika für 244 Mio USD im Juni 2024
- SK bioscience Expands Integrated Vaccine Manufacturing Through IDT Biologika Partnership
- SK Bioscience and IDT Biologika partner to produce MSD’s Zaire Ebola Vaccine with $30M CEPI funding
- SK Bioscience, subsidiary IDT, sign CDMO deal with MSD for Ebola Vaccine
- SK bioscience and IDT Biologika to develop drug product for MSD’s Zaire Ebola Vaccine
- SK bioscience and IDT Biologika to develop drug product for MSD’s Zaire Ebola Vaccine
- SK Bioscience, IDT Sign Ebola Vaccine CDMO Deal With MSD
- SK bioscience, IDT sign MSD Ebola vaccine manufacturing deal
- SK Bioscience Signs Contract Manufacturing Agreement with IDT for MSD Ebola Vaccine
- SK bioscience secures EU project for patch-type flu vaccine
- SK bioscience revenue jumps 144% in 2025 as IDT turns profitable
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come IDT Biologika?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili